51 results
8-K
EX-99.1
RNXT
RenovoRx Inc
18 Apr 24
Other Events
4:15pm
to be incorrect. These may include estimates, projections and statements relating to our research and development plans, clinical trials, therapy platform, business
8-K
EX-99.1
RNXT
RenovoRx Inc
15 Apr 24
Unregistered Sales of Equity Securities
9:00am
to our research and development plans, clinical trials, therapy platform, business plans, financing plans, objectives and expected operating results
8-K
EX-99.1
3xs3td
9 Apr 24
RenovoRx Announces $11.1 Million At Market Private Placement
4:15pm
8-K
EX-99.1
cr7l0
29 Jan 24
RenovoRx Closes $6.1 Million Private Placement
9:06am
8-K
EX-99.1
xa23758
14 Nov 23
RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
12:00am
8-K
EX-99.1
64l3enqdalki 2klrzj
17 Aug 23
RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
8:30am
424B3
ndlkz dpkhubvv
19 May 23
Prospectus supplement
5:07pm
8-K
EX-99.1
uz8s8sabhca 2pkv
15 May 23
RenovoRx Reports First Quarter 2023 Financial Results and Operational Highlights
8:30am
8-K
EX-99.1
5d8tix67xcxk
3 Apr 23
RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:45pm
424B5
2bd0ti77 m1m
3 Apr 23
Prospectus supplement for primary offering
9:00am